HS-tk vector bearing the gene for thymidine kinase: Began Phase I/II trial in 15 patients, with direct injection of the vector into tumor, followed by treatment

Genetic Therapy Inc. (GTII),

Read the full 49 word article

How to gain access

Continue reading with a
two-week free trial.